维拉帕米（异搏定）对心血管系统的某些作用。 - Suppr

Suppr

超能文献

Some effects of iproveratril (Isoptin) on the cardiovascular system.

作者信息

Nayler W G, McInnes I, Swann J B, Price J M, Carson V, Race D, Lowe T E

出版信息

J Pharmacol Exp Ther. 1968 Jun;161(2):247-61.

PMID:5650138

Abstract

摘要

相似文献

Some effects of iproveratril (Isoptin) on the cardiovascular system.维拉帕米（异搏定）对心血管系统的某些作用。

J Pharmacol Exp Ther. 1968 Jun;161(2):247-61.

[Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].[不同血管及心肌活性物质在急性试验中有效性的比较动物实验研究]

Z Gesamte Inn Med. 1969 Feb 15;24(4):102-8.

Cardiovascular actions of iproveratril.维拉帕米的心血管作用。

J Pharmacol Exp Ther. 1967 Dec;158(3):504-9.

[Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].

Pflugers Arch. 1969;312(1):R8-9.

[Hemodynamic properties of a new derivative of theophylline: bamifylline].

Schweiz Med Wochenschr. 1970 Mar 7;100(10):462-7.

[The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].[口服维拉帕米对人体心脏冠状动脉血流、氧消耗及二氧化碳生成的影响]

Arzneimittelforschung. 1971 Apr;21(4):462-5.

Prevention of ventricular fibrillation induced by coronary ligation.预防冠状动脉结扎诱发的心室颤动。

J Pharmacol Exp Ther. 1968 Dec;164(2):326-32.

Adrenergic mechanisms in the initiation of cardiac arrhythmias.

Arch Int Pharmacodyn Ther. 1969 Dec;182(2):376-90.

[A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].[一组对哺乳动物心肌电机械偶联具有强大抑制作用的新型竞争性二价钙拮抗剂（维拉帕米、D600、普尼拉明）]

Pflugers Arch. 1969;307(2):R25.

Verapamil in cardiology.维拉帕米在心脏病学中的应用。

Eur J Cardiol. 1974 Aug;2(1):3-10.

引用本文的文献

Discovery and Development of Calcium Channel Blockers.钙通道阻滞剂的发现与研发

Front Pharmacol. 2017 May 29;8:286. doi: 10.3389/fphar.2017.00286. eCollection 2017.

Antihypertensive and renal effects of orally administered verapamil.口服维拉帕米的降压及肾脏效应

Eur J Clin Pharmacol. 1980 Nov;18(5):375-82. doi: 10.1007/BF00636788.

Additive antianginal effect of verapamil in patients receiving propranolol.维拉帕米对接受普萘洛尔治疗患者的附加抗心绞痛作用。

Br Med J (Clin Res Ed). 1982 Apr 10;284(6322):1067-70. doi: 10.1136/bmj.284.6322.1067.

Clinical pharmacokinetics of verapamil.维拉帕米的临床药代动力学

Clin Pharmacokinet. 1984 Jan-Feb;9(1):26-41. doi: 10.2165/00003088-198409010-00002.

Calcium antagonists: definition and mode of action.钙拮抗剂：定义与作用方式。

Basic Res Cardiol. 1981 Jan-Feb;76(1):1-15. doi: 10.1007/BF01908159.

Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties.有证据表明，具有钙拮抗剂特性的药物地尔硫䓬不具有β-肾上腺素受体阻断活性。

Br J Pharmacol. 1980 Aug;69(4):669-73. doi: 10.1111/j.1476-5381.1980.tb07920.x.

[Effect of verapamil on coronary blood flow, oxygen utilisation and carbon dioxide production in human heart].维拉帕米对人体心脏冠状动脉血流、氧利用及二氧化碳生成的影响

Klin Wochenschr. 1971 Sep 1;49(17):982-8. doi: 10.1007/BF01489464.

Effect of verapamil in obstructive airways disease.维拉帕米在阻塞性气道疾病中的作用。

Eur J Clin Pharmacol. 1974;7(1):61-4. doi: 10.1007/BF00614392.

Verapamil and the myocardium.维拉帕米与心肌

Postgrad Med J. 1974 Jul;50(585):441-6. doi: 10.1136/pgmj.50.585.441.

Verapamil in the treatment of paroxysmal supraventricular tachycardia.维拉帕米治疗阵发性室上性心动过速

Postgrad Med J. 1974 Jul;50(585):447-53. doi: 10.1136/pgmj.50.585.447.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验